CSIMarket
 


Candel Therapeutics Inc   (CADL)
Other Ticker:  
 


Candel Therapeutics Inc 's Net Cash Flow Margin by quarter

Trends, Rankings, Statistics



CADL Net Cash Flow Margin (Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter



Y / Y Revenue Change - - - - -
Seq. Revenue Change 0 % - - - -
Revenue In Millions $0.03 $0.03 $0.00 $0.00 $0.00
Net Cash Flow Margin - - - - -
Net Cash Flow Margin Total Ranking # 13 # # # #
Net Cash Flow In Millions $64.07 $-10.58 $0.00 $0.00 $0.00
Y / Y Net Cash Flow Change - - - - -
Seq. Net Cash Flow Change - - - - -


Commenting Third Quarter 2021 Net Cash Flow Margin
Company's Net Cash Flow Margin improved in III. Quarter to 206674.19 %, a new company low.

Observing third quarter 2021 results within Biotechnology & Pharmaceuticals industry Candel Therapeutics Inc has achieved highest Net Cash Flow Margin. While Net Cash Flow Margin overall ranking has deteriorated compare to previous quarter from to 13.

CADL's Net Cash Flow Margin third quarter 2021 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 1
Healthcare Sector # 5
Overall # 13

Net Cash Flow Margin Statistics
High Average Low
206674.19 % 206674.19 % 206674.19 %
(Sep 30 2021)  




Other Net Cash Flow Margin Profitability Ratios
CADL's Cumulative Net Cash Flow Margin
Biotechnology & Pharmaceuticals Industry Net Cash Flow Margin Trends and Statistics
Healthcare Sector Net Cash Flow Margin Statistics
Net Cash Flow Margin Profitability Trends for overall market
CADL's Net Cash Flow Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Margin
Lowest Ranking Net Cash Flow Margin
Net Cash Flow Margin Profit Margin for CADL's Competitors
Net Cash Flow Margin Profit Margin for Candel Therapeutics Inc 's Suppliers
Net Cash Flow Margin Profit Margin for CADL's Customers

You may also want to know
CADL's Annual Growth Rates CADL's Profitability Ratios CADL's Asset Turnover Ratio CADL's Dividend Growth
CADL's Roe CADL's Valuation Ratios CADL's Financial Strength Ratios CADL's Net Cash Flow Growth
CADL's Roa CADL's Inventory Turnover Ratio CADL's Growth Rates CADL's Dividend Comparisons


Companies with similar Net Cash Flow Margin in the quarter ending Sep 30 2021, within Biotechnology & Pharmaceuticals Industry Net Cash Flow MarginSep 30 2021 MRQ Net Cash FlowSep 30 2021 MRQ Revenue
Candel Therapeutics Inc   206,674.19 %$ 64.069 $ 0.031 
Petvivo Holdings Inc  174,289.49 %$ 8.674 $ 0.005 
Humacyte Inc   83,498.49 %$ 201.231 $ 0.241 
Beam Therapeutics Inc   52,425.69 %$ 400.008 $ 0.763 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TRIS's Profile

Stock Price

TRIS's Financials

Business Description

Fundamentals

Charts & Quotes

TRIS's News

Suppliers

TRIS's Competitors

Customers & Markets

Economic Indicators

TRIS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071